The spring 2026 conference season made one thing obvious to those of us watching the data: the artisan era of ex vivo cellular manufacturing is finally receding.
- A Comparison Of 6 Analytical Validation Guidelines Using Data Envelopment Analysis
- Inside AstraZeneca's Fully Electrified Cell Therapy Facility
- AI Has Arrived In Biotech CMC Amid Patchwork Governance
- Driving Gene Therapy Beyond Rare Disease Will Define The Next Era Of CGT
- CDMO Selection: Start With The Relationship, Not The RFP
- Why FAT Should Confirm Alignment, Not Reveal Its Absence
- Managing Supply Disruptions In ATIMP Clinical Trials
- Why Cell And Gene Therapy Has Not Reached More Patients — And Why Clinical Operations Is The Bridge
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![antibody molecules-GettyImages-2165626333]( "ADC Development Grows More Complex — SPR Insights Bring Clarity")
ADC Development Grows More Complex — SPR Insights Bring ClarityExplore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.
-
![GettyImages-1626470215-cluster-cells-stem-cells-blue]( "Molecular Approaches To Streamline Cell Therapy Product Analytical Testing")
Molecular Approaches To Streamline Cell Therapy Product Analytical TestingLearn how rapid molecular methods of cell therapy testing like qPCR for mycoplasma, sterility, and lentiviral quantification are key to accelerating product release and timely treatment delivery.
-
![GettyImages-158649166 assay]( "Commercial Success Starts With A Fit-For-Purpose Flow Cytometer")
Commercial Success Starts With A Fit-For-Purpose Flow CytometerDiscover how standardizing reagents and automating flow cytometry workflows can improve reproducibility, reduce troubleshooting, and accelerate progress in cell-based therapies.
-
![GettyImages-1212712327 cell cultures]( "How Can I Increase My Viral Titers And Improve The Percentage Of Full AAVs?")
How Can I Increase My Viral Titers And Improve The Percentage Of Full AAVs?Explore various strategies to enhance viral titer and increase the percentage of full AAV capsids, like modifications to transfection reagents, cell lines, media, procedures, and more.
-
![GettyImages-2174865907 workflow, lab, cell therapy]( "Successful Cell-Based ADA Collaboration In mRNA Gene Replacement Therapy")
Successful Cell-Based ADA Collaboration In mRNA Gene Replacement TherapyA biotech firm developed a rapid, sensitive, cell-based ADA assay through collaborative innovation, reducing variability and turnaround time while improving performance for mRNA gene therapy.
-
![GettyImages-1142684567 cell culture]( "A Beginner's Guide To Sf9 Culture In Stirred-Tank Bioreactors")
A Beginner's Guide To Sf9 Culture In Stirred-Tank BioreactorsLearn about the workflow steps for Sf9 cell expansion, virus preparation, and protein production in stirred-tank bioreactors, including GFP expression.
-
![GettyImages-2148703252-DNA-helix-blue]( "Automated Library Prep For Nanopore Human Whole Genome Sequencing")
Automated Library Prep For Nanopore Human Whole Genome SequencingGain insight into an automated high‑input workflow that streamlines long‑read whole‑genome library prep, supporting large DNA fragments while reducing reagent use.
-
![GettyImages-1317697237-CAR-T-Cells-Therapy]( "Determination Of Immune Cell Composition And CAR-T Cells")
Determination Of Immune Cell Composition And CAR-T CellsDiscover a system that automates CAR-T cell production using flow cytometry and analyzers for precise monitoring as well as learn about the sample preparation, instrument setup, and data analysis.
-
![GettyImages-1457289257 patient]( "Quantitative ROI With DCTs")
Quantitative ROI With DCTsThrough dedicated staffing, operational oversight, and collaboration with site teams, see how we were able to transform a struggling cardiology study into a revitalized recruitment effort.
-
![Global logistics supply chain-GettyImages-2256982707]( "An Innovative, Modular Approach To Flexible Supply Chain Management")
An Innovative, Modular Approach To Flexible Supply Chain ManagementLearn how modular strategies, global coordination, and data-driven decisions help maintain continuity, compliance, and speed amid constant uncertainty.
NEWSLETTER ARCHIVE
- 06.10.26 -- Control Contamination In Material Transfer Process
- 06.10.26 -- Bioprocess Innovation In Action: Insights, Expertise, And New Solutions
- 06.10.26 -- The Future Of In Vivo Gene Editing And Clinical Translation
- 06.09.26 -- STREAM Edition: The Future Of In Vivo Gene Editing And Clinical Translation With Precision Biosciences' Cassie Gorsuch, Ph.D.
- 06.09.26 -- Making Distributed Manufacturing Work Beyond Theory
- Driving Gene Therapy Beyond Rare Disease Will Define The Next Era Of CGT
- CGT Manufacturing Shifts From Capacity To Strategy
- Dr. Peter Marks On Why Gene Therapy May Need A New Regulatory Playbook
- Regeneron Advances In Vivo Gene Therapy For Hearing Loss
- Sana, Mayo Clinic Advance A New Model For Cell Therapy Delivery In T1D
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
